Introduction

The Fleming Fund (FF) is a U.K. Department of Health and Social Care programme to help low and middle-income countries fight Antimicrobial Resistance (AMR). AMR poses a severe global threat, expected to cause 10 million deaths annually by 2050. With potential costs reaching $100 trillion, its impact on the global economy is significant. Fleming Fund Grants aim to tackle the AMR challenge in developing countries including Pakistan. The grants are funded by the UK Department of Health and Social Care and managed by Mott MacDonald for the country, regional and fellowship grants. Pakistan has received Fleming Fund support since 2019 in the form of two Country Grants, 9 Fellowships, and central and local procurement of equipment, reagents, and consumables. Between 2017 and the end of phase-1 of the program in March 2023, the program has provided financial support to grantees to establish and support local development of national AMR surveillance systems.

In partnership with the Fleming Fund, DAI's programme in Pakistan collaborates with the Pakistani government to strengthen systems using a “One Health” (OH) approach – a multisectoral approach to complex health problems that reaches across human health, animal health, and environment sectors. As global leaders in One Health, the DAI team helps incorporate One Health across programme interventions. DAI is helping Pakistan become a leader in combating antimicrobial resistance, and a model for better management of antimicrobials in human and animal populations. DAI and its consortium partners have successfully secured an additional round, Phase 2, of the Fleming Fund Country Grant in Pakistan which spans from January 2024 to December 2025. The Phase 2 of the FFCG programme focuses on achieving four intermediate outcomes: 1) Production of quality AMR/U/C and burden of disease data; 2) Conducting quality data analysis; 3) Sharing quality data analysis with decision-makers; and 4) Contributing to sustainable investments at both the country and global levels to counter AMR.

Position Summary

Under the overarching guidance of the Senior Manager OH (Governance and Advocacy), the Consultant will lead the development of a detailed Costed Multisectoral OH Procurement Plan for four sentinel sites one each in Human Health, Animal Health, Aquaculture and Environment.

Key Objectives:

The consultant will be expected to develop:

• A narrative procurement plan that outlines the sector wise sentinel site requirements with procurement specifications, in alignment with AMR NAP 2.0.
• A costed procurement plan (in Excel) detailing:

- Equipment requirement for fully equipping the Human Health, Animal Health, Aquaculture Health, and Environment Health sentinel sites.
- Routine operationalization and running costs (consumables, and reagents). Reagents, consumables, lab equipment and their maintenance cost information are to be made separately.

Requirements (Education, Experience, Skills, Languages etc.):

• Master’s degree (or higher) in Procurement/Supply Chain Management, Logistics and Finance or a related field.
• Minimum 10 years of relevant experience in public health procurement planning and health systems strengthening. Experience in laboratory related procurement will be highly preferable.
• Proven work experience with government stakeholders, donor-funded health programs, and international partners.
• Strong understanding of One Health, AMR containment strategies, and global health policies.
• Demonstrated skills in procurement analysis, costing, and strategic planning.
• Proficiency in MS Office and relevant project planning tools.
• Strong verbal and written communication skills in English.